Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1964 Nov 1;120(5):841-56.
doi: 10.1084/jem.120.5.841.

INTERFERENCE WITH IMMUNE HEMOLYSIS BY GLYCOPROTEIN ANTIGENS

INTERFERENCE WITH IMMUNE HEMOLYSIS BY GLYCOPROTEIN ANTIGENS

E R ARQUILLA et al. J Exp Med. .

Abstract

1. The titer of an individual insulin antiserum measured by hemagglutination agrees favorably with the titer of the same antiserum as measured by immune hemolysis. 2. In contrast, a marked decrease is noted in the immune hemolysis titers relative to hemagglutination titers of antisera prepared against three different sialic acid-containing proteins (human chorionic gonadotropin, rabbit transferrin, and human transferrin). 3. The lower immune hemolytic titers of glycoprotein antisera are apparently not due to a lack of complement-fixing gamma(2)-antibodies. 4. The glycoprotein antigens in solution do not interfere with hemolysis in the insulin immune system. 5. By contrast, marked inhibition of insulin immune hemolysis occurs when cells are sensitized with both glycoprotein and insulin. 6. Cells treated with neuraminidase (to remove cell surface sialic acid) lyse in the presence of C'(a) alone. 7. If neuraminidase-treated cells are sensitized with sialic acid-containing protein, the lysis of these cells by complement is inhibited. 8. It is, therefore, postulated that during some initial phase of immune hemolysis, a sialic acid-containing substrate is cleaved from the cell surface, rendering the cell susceptible to lysis. If this removal is interfered with, i.e., by sensitization of the cell with competitive sialic acid-containing antigen, then the lytic portion of immune hemolysis cannot proceed.

PubMed Disclaimer

References

    1. J Exp Med. 1945 May 1;81(5):449-68 - PubMed
    1. J Exp Med. 1963 Jun 1;117:965-81 - PubMed
    1. J Clin Invest. 1963 Apr;42:546-55 - PubMed
    1. J Clin Invest. 1956 May;35(5):458-66 - PubMed
    1. J Immunol. 1963 Jun;90:843-8 - PubMed